Alto Neuroscience Inc
(ANRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANRO | KROS | NMRA | ||
| Company | Alto Neuroscience Inc | Keros Therapeutics Inc | Neumora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 16.66 | 17.02 | 2.93 | ||
| High | 16.80 | 17.08 | 3.02 | ||
| Low | 15.56 | 16.31 | 2.77 | ||
| Latest | 16.71 | 17.04 | 3.00 | ||
| Change | +0.06 | -0.11 | +0.01 | ||
| % Change | +0.36% | -0.64% | +0.33% | ||
| Volume | 213,700 | 352,900 | 2,170,100 | ||
| 20-Day Average Volume | 205,090 | 279,850 | 1,562,050 | ||
| Previous Close | 16.65 | 17.15 | 2.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.30 | 18.30 | 2.15 | ||
| 20-Day Raw Stochastic | 61.00% | 20.11% | 92.06% | ||
| 20-Day Relative Strength | 53.46 | 40.05 | 71.05 | ||
| Weighted Alpha | +107.71 | +43.02 | -12.81 | ||
| Today's Opinion | 72% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 80% Buy | 24% Buy | 72% Buy | ||
| Last Month's Opinion | 80% Buy | 72% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.40% since 02/04/26 | -5.60% since 02/04/26 | +48.51% since 02/04/26 | ||
| Low | 13.91 on 02/06/26 | 16.31 on 02/11/26 | 1.92 on 02/05/26 | ||
| High | 16.85 on 02/10/26 | 18.16 on 02/05/26 | 3.10 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +2.08% since 01/09/26 | -11.25% since 01/09/26 | +35.14% since 01/09/26 | ||
| Low | 13.91 on 02/06/26 | 16.31 on 02/11/26 | 1.84 on 01/20/26 | ||
| High | 18.50 on 01/20/26 | 19.94 on 01/23/26 | 3.10 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +24.70% since 11/11/25 | +0.83% since 11/11/25 | +9.09% since 11/11/25 | ||
| Low | 10.80 on 11/14/25 | 16.31 on 02/11/26 | 1.50 on 01/06/26 | ||
| High | 20.91 on 12/19/25 | 22.55 on 12/08/25 | 3.10 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | +446.08% since 08/11/25 | +27.64% since 08/11/25 | +108.33% since 08/11/25 | ||
| Low | 3.02 on 08/14/25 | 13.44 on 08/12/25 | 1.39 on 08/12/25 | ||
| High | 20.91 on 12/19/25 | 22.55 on 12/08/25 | 3.25 on 10/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 517,249 | 522,492 | 499,596 | ||
| Shares Outstanding, K | 31,066 | 30,466 | 167,089 | ||
| Annual Sales | 0 | 3,550,000 | 0 | ||
| Annual Net Income | -61,430,000 | -187,350,000 | -243,790,000 | ||
| Last Quarter Sales | 0 | 14,260,000 | 0 | ||
| Last Quarter Net Income | -14,180,000 | -7,280,000 | -56,760,000 | ||
| 60-Month Beta | 2.78 | 0.86 | 3.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 11/12/25 | -0.18 on 11/05/25 | -0.35 on 11/06/25 | ||
| Latest Earnings Date | 03/19/26 | 02/25/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.38 | 0.00 | ||